Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.
ACASTI PHARM-TS (V.APO) had Earnings per Share (EPS) (Diluted) of -2.54 for the most recently reported fiscal quarter, ending 2018-12-31.
| Income Statement Financials | |
-- |
|
-3.49M |
|
-- |
|
-- |
|
-- |
|
-8.10M |
|
-- |
|
-3.49M |
|
-3.49M |
|
-3.49M |
|
-3.49M |
|
-3.49M |
|
-3.49M |
|
-8.10M |
|
-7.56M |
|
1.48M |
|
1.48M |
|
-2.54 |
|
|
Earnings per Share (EPS) (Diluted) |
-2.54 |
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
45.14M |
|
-- |
|
-- |
|
-- |
|
21.97M |
|
23.17M |
|
16.87M |
|
23.17M |
|
1.63M |
|
| Cash Flow Statement Financials | |
-16.75M |
|
-13.08M |
|
44.90M |
|
6.22M |
|
21.86M |
|
15.64M |
|
0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.05% |
|
-20.67% |
|
-7.73% |
|
-14.23% |
|
18.81 |
|
-11.73 |
|
-11.35 |
|